Merkhof, L.F.M. van den

patient abciximab infarction study angioplasty trial patency tissue plasminogen activator grade glycoprotein emergency room therapy artery 45 min antagonist emergency abciximab bolus heparin infarct-related artery receptor result thrombolytic thrombolysi thrombolytic therapy reperfusion pilot netherland infarct-related symptom catheterization laboratory /iiia activator aspirin plasminogen platelet ami jacc vol investigator van den merkhof grape interval effect onset tissue hospital ef ficacy range cardiology strategy treatment american college injection randomised trial infusion patency enhancement university hospital comparison catheterization angiography contrast evaluation dose bolus heparin emergency room initiation laboratory university fi brin streptokinase dose heparin bolus randomised merkhof circulation initiation american ficacy angina college fidence observation administration percutaneous transluminal glycoprotein antagonists